Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How should treatment costs impact on physician's decisions?

N Neymark1

  • 1EORTC Health Economics Unit, Brussels, Belgium.

Acta Oto-Rhino-Laryngologica Belgica
|January 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the economic value of epoetin use in anemic cancer patients.

Expert review of pharmacoeconomics & outcomes research·2009
Same author

The costs of treating glaucoma with combinations of topical drugs in Spain.

European journal of ophthalmology·2008
Same author

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.

European urology·2003
Same author

Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer.

Health economics·2002
Same author

Health Economics Unit achievements.

European journal of cancer (Oxford, England : 1990)·2002
Same author

Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis.

European journal of cancer (Oxford, England : 1990)·2001
Same journal

[Allergy and vasomotor disorders of the sinusal and nasal mucosa].

Acta oto-rhino-laryngologica Belgica·2014
Same journal

Hairy tongue: a case report.

Acta oto-rhino-laryngologica Belgica·2005
Same journal

Ultrasonography as the method of incidental detection of mandible lesions.

Acta oto-rhino-laryngologica Belgica·2005
Same journal

Extracranial sinonasal tract meningioma: a case report.

Acta oto-rhino-laryngologica Belgica·2005
Same journal

Cartilage and tympanoplasty.

Acta oto-rhino-laryngologica Belgica·2005
Same journal

Facial pain from visceral origin.

Acta oto-rhino-laryngologica Belgica·2005
See all related articles

Cost considerations are most valuable for policy decisions in clinical settings, guiding treatment options. Economic evaluations aid decision-makers in selecting cost-effective healthcare strategies.

Area of Science:

  • Health Economics
  • Clinical Decision Making
  • Health Policy

Background:

  • Cost considerations are crucial in healthcare.
  • Identifying the optimal level for cost assessment is essential for effective resource allocation.
  • Clinical decisions are influenced by available treatment options and protocols.

Purpose of the Study:

  • To determine the most pertinent level for cost considerations in clinical decision-making.
  • To highlight the value of cost assessments at the policy-making level.
  • To introduce methods of economic evaluation for informed policy decisions.

Main Methods:

  • Discussion of the relevance of cost considerations at different levels of clinical decision-making.
  • Argument for the importance of intermediate-level policy decisions.

Related Experiment Videos

  • Introduction to economic evaluation methodologies.

    • Main Results:

    • Cost assessments are most relevant at the intermediate policy-making level (e.g., formulary decisions, treatment protocols).
    • Policy decisions establish the framework for individual patient-physician encounters.
    • Economic evaluation methods provide data for evidence-based policy decisions.

    Conclusions:

    • Policy-level cost assessments are vital for guiding clinical practice.
    • Economic evaluation methods support informed decision-making in healthcare.
    • Integrating cost-benefit analyses into policy enhances resource allocation and treatment selection.